Home/Filings/4/0001209191-23-026066
4//SEC Filing

List Alan 4

Accession 0001209191-23-026066

CIK 0001357874other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 4:53 PM ET

Size

9.3 KB

Accession

0001209191-23-026066

Insider Transaction Report

Form 4
Period: 2023-04-26
List Alan
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-26+26,02764,267 total
  • Sale

    Common Stock

    2023-04-27$0.79/sh7,771$6,13956,496 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-04-2626,02726,028 total
    Common Stock (26,027 underlying)
Footnotes (4)
  • [F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2023.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  • [F4]On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1
  • filerCIK 0001858530

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:53 PM ET
Size
9.3 KB